Researcher profile

Weina Jin

Weina Jin contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

EUCA: the End-User-Centered Explainable AI Framework

The ability to explain decisions to end-users is a necessity to deploy AI as critical decision support. Yet making AI explainable to non-technical end-users is a relatively ignored and challenging problem. To bridge the gap, we first identify twelve end-user-friendly explanatory forms that do not require technical knowledge to comprehend, including feature-, example-, and rule-based explanations. We then instantiate the explanatory forms as prototyping cards in four AI-assisted critical decision-making tasks, and conduct a user study to co-design low-fidelity prototypes with 32 layperson participants. The results confirm the relevance of using explanatory forms as building blocks of explanations, and identify their proprieties - pros, cons, applicable explanation goals, and design implications. The explanatory forms, their proprieties, and prototyping supports (including a suggested prototyping process, design templates and exemplars, and associated algorithms to actualize explanatory forms) constitute the End-User-Centered explainable AI framework EUCA, and is available at http://weinajin.github.io/end-user-xai . It serves as a practical prototyping toolkit for HCI/AI practitioners and researchers to understand user requirements and build end-user-centered explainable AI.

preprint2020arXiv

Artificial Intelligence in Glioma Imaging: Challenges and Advances

Primary brain tumors including gliomas continue to pose significant management challenges to clinicians. While the presentation, the pathology, and the clinical course of these lesions are variable, the initial investigations are usually similar. Patients who are suspected to have a brain tumor will be assessed with computed tomography (CT) and magnetic resonance imaging (MRI). The imaging findings are used by neurosurgeons to determine the feasibility of surgical resection and plan such an undertaking. Imaging studies are also an indispensable tool in tracking tumor progression or its response to treatment. As these imaging studies are non-invasive, relatively cheap and accessible to patients, there have been many efforts over the past two decades to increase the amount of clinically-relevant information that can be extracted from brain imaging. Most recently, artificial intelligence (AI) techniques have been employed to segment and characterize brain tumors, as well as to detect progression or treatment-response. However, the clinical utility of such endeavours remains limited due to challenges in data collection and annotation, model training, and the reliability of AI-generated information. We provide a review of recent advances in addressing the above challenges. First, to overcome the challenge of data paucity, different image imputation and synthesis techniques along with annotation collection efforts are summarized. Next, various training strategies are presented to meet multiple desiderata, such as model performance, generalization ability, data privacy protection, and learning with sparse annotations. Finally, standardized performance evaluation and model interpretability methods have been reviewed. We believe that these technical approaches will facilitate the development of a fully-functional AI tool in the clinical care of patients with gliomas.